Beta-cell recovery to counter diabetes

Project Information

DiogenX

Grant agreement ID: 190133766

DOI

10.3030/190133766

Project closed

EC signature date 30 November 2023

Start date 1 October 2023

End date 30 September 2025

Funded under

• The European Innovation Council (EIC)

Total cost

€ 5 673 000,00

EU contribution

€ 2 500 000,00

Coordinated by

DIOGENX SAS
France

CORDIS provides links to public deliverables and publications of HORIZON projects.

Links to deliverables and publications from FP7 projects, as well as links to some specific result types such as dataset and software, are dynamically retrieved from OpenAIRE .

Publications

Peer reviewed articles (2)

Wnt Pathway in Pancreatic Development and Pathophysiology

Author(s): Tiziana Napolitano, Serena Silvano, Chaïma Ayachi, Magali Plaisant, Anette Sousa-Da-Veiga, Hugo Fofo, Benjamin Charles, Patrick Collombat
Published in: Cells, Issue 12, 2023, ISSN 2073-4409
Publisher: MDPI AG
DOI: 10.3390/cells12040565

RSPO1, a potent inducer of pancreatic β cell neogenesis

Author(s): Serena Silvano, Tiziana Napolitano, Magali Plaisant, Anette Sousa-De-Veiga, Hugo Fofo, Chaïma Ayachi, Benoit Allegrini, Samah Rekima, Estelle Pichery, Jérôme Becam, Valentin Lepage, Caroline Treins, Laura Etasse, Loan Tran, Julien Thévenet, Gianni Pasquetti, Julie Kerr-Conte, François Pattou, Paolo Botti, Arduino Arduini, Jacques Mizrahi, Benjamin Charles, Patrick Collombat
Published in: Cell Reports Medicine, Issue 6, 2025, ISSN 2666-3791
Publisher: Elsevier BV
DOI: 10.1016/J.XCRM.2025.102126

Intellectual Property Rights

Patent (2)

RECOMBINANT VARIANTS OF R-SPONDIN PROTEINS AND THEIR USE

Application/Publication number: 20 24051193
Date: 2024-01-18
Applicant(s): DIOGENX SAS

RECOMBINANT VARIANTS OF R-SPONDIN PROTEINS AND THEIR USE

Application/Publication number: 20 24051193
Date: 2024-01-18
Applicant(s): DIOGENX SAS